ロード中...
Does the leading pharmaceutical reform in China really solve the issue of overly expensive healthcare services? Evidence from an empirical study
BACKGROUND: Healthcare system reform of Sanming city has become a leading healthcare reform model in China. It has developed a rigorous pharmaceutical reform consisted of the Zero Mark-up Drug Policy and the Centralized Procurement of Medicine Policy to bring down drug expenses and total health expe...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5770029/ https://ncbi.nlm.nih.gov/pubmed/29338038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0190320 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|